Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

[Senescent cells: a target in osteo-articular diseases].

Tachikart Y, Malaise O, Constantinides M, Jorgensen C, Brondello JM.

Med Sci (Paris). 2018 Jun-Jul;34(6-7):547-553. doi: 10.1051/medsci/20183406014. Epub 2018 Jul 31. Review. French.

PMID:
30067213
2.

Secreted α-Klotho maintains cartilage tissue homeostasis by repressing NOS2 and ZIP8-MMP13 catabolic axis.

Chuchana P, Mausset-Bonnefont AL, Mathieu M, Espinoza F, Teigell M, Toupet K, Ripoll C, Djouad F, Noel D, Jorgensen C, Brondello JM.

Aging (Albany NY). 2018 Jun 19;10(6):1442-1453. doi: 10.18632/aging.101481.

3.

Cell Connections by Tunneling Nanotubes: Effects of Mitochondrial Trafficking on Target Cell Metabolism, Homeostasis, and Response to Therapy.

Vignais ML, Caicedo A, Brondello JM, Jorgensen C.

Stem Cells Int. 2017;2017:6917941. doi: 10.1155/2017/6917941. Epub 2017 Jun 4. Review.

4.

Cellular senescence impact on immune cell fate and function.

Vicente R, Mausset-Bonnefont AL, Jorgensen C, Louis-Plence P, Brondello JM.

Aging Cell. 2016 Jun;15(3):400-6. doi: 10.1111/acel.12455. Epub 2016 Feb 22. Review.

5.

MitoCeption as a new tool to assess the effects of mesenchymal stem/stromal cell mitochondria on cancer cell metabolism and function.

Caicedo A, Fritz V, Brondello JM, Ayala M, Dennemont I, Abdellaoui N, de Fraipont F, Moisan A, Prouteau CA, Boukhaddaoui H, Jorgensen C, Vignais ML.

Sci Rep. 2015 Mar 13;5:9073. doi: 10.1038/srep09073.

6.

p16INK4a and its regulator miR-24 link senescence and chondrocyte terminal differentiation-associated matrix remodeling in osteoarthritis.

Philipot D, Guérit D, Platano D, Chuchana P, Olivotto E, Espinoza F, Dorandeu A, Pers YM, Piette J, Borzi RM, Jorgensen C, Noel D, Brondello JM.

Arthritis Res Ther. 2014 Feb 27;16(1):R58. doi: 10.1186/ar4494.

7.

FOXO3A regulation by miRNA-29a Controls chondrogenic differentiation of mesenchymal stem cells and cartilage formation.

Guérit D, Brondello JM, Chuchana P, Philipot D, Toupet K, Bony C, Jorgensen C, Noël D.

Stem Cells Dev. 2014 Jun 1;23(11):1195-205. doi: 10.1089/scd.2013.0463. Epub 2014 Mar 21.

PMID:
24467486
8.

Sox9-regulated miRNA-574-3p inhibits chondrogenic differentiation of mesenchymal stem cells.

Guérit D, Philipot D, Chuchana P, Toupet K, Brondello JM, Mathieu M, Jorgensen C, Noël D.

PLoS One. 2013 Apr 23;8(4):e62582. doi: 10.1371/journal.pone.0062582. Print 2013.

9.

Induction of ASAP (MAP9) contributes to p53 stabilization in response to DNA damage.

Basbous J, Knani D, Bonneaud N, Giorgi D, Brondello JM, Rouquier S.

Cell Cycle. 2012 Jun 15;11(12):2380-90. doi: 10.4161/cc.20858. Epub 2012 Jun 15.

PMID:
22672907
10.

[Cellular senescence and the myth of Janus].

Brondello JM, Prieur A, Philipot D, Lemaitre JM, Lenaers G, Piette J, Dulić V.

Med Sci (Paris). 2012 Mar;28(3):288-96. doi: 10.1051/medsci/2012283017. Epub 2012 Apr 6. Review. French.

11.

Bone-metastatic prostate carcinoma favors mesenchymal stem cell differentiation toward osteoblasts and reduces their osteoclastogenic potential.

Fritz V, Brondello JM, Gordeladze JO, Reseland JE, Bony C, Yssel H, Noël D, Jorgensen C.

J Cell Biochem. 2011 Nov;112(11):3234-45. doi: 10.1002/jcb.23258.

PMID:
22009438
12.

Cellular Senescence is a Common Characteristic Shared by Preneoplasic and Osteo-Arthritic Tissue.

Brondello JM, Philipot D, Djouad F, Jorgensen C, Noël D.

Open Rheumatol J. 2010 Feb 11;4:10-4. doi: 10.2174/1874312901004010010.

13.

Cartilage tissue engineering: towards a biomaterial-assisted mesenchymal stem cell therapy.

Vinatier C, Bouffi C, Merceron C, Gordeladze J, Brondello JM, Jorgensen C, Weiss P, Guicheux J, Noël D.

Curr Stem Cell Res Ther. 2009 Dec;4(4):318-29. Review.

14.

Concerted stimuli regulating osteo-chondral differentiation from stem cells: phenotype acquisition regulated by microRNAs.

Gordeladze JO, Djouad F, Brondello JM, Noël D, Duroux-Richard I, Apparailly F, Jorgensen C.

Acta Pharmacol Sin. 2009 Oct;30(10):1369-84. doi: 10.1038/aps.2009.143. Review.

15.

Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol zeta.

Brondello JM, Pillaire MJ, Rodriguez C, Gourraud PA, Selves J, Cazaux C, Piette J.

Oncogene. 2008 Oct 16;27(47):6093-101. doi: 10.1038/onc.2008.212. Epub 2008 Jul 14.

PMID:
18622427
16.

Linking PCNA-dependent replication and ATR by human Claspin.

Brondello JM, Ducommun B, Fernandez A, Lamb NJ.

Biochem Biophys Res Commun. 2007 Mar 23;354(4):1028-33. Epub 2007 Jan 25.

PMID:
17274954
17.

DNA damage checkpoint kinase Chk2 triggers replicative senescence.

Gire V, Roux P, Wynford-Thomas D, Brondello JM, Dulic V.

EMBO J. 2004 Jul 7;23(13):2554-63. Epub 2004 Jun 10.

18.

Synthesis and inhibition properties of conformational probes for the mutase-catalyzed UDP-galactopyranose/furanose interconversion.

Caravano A, Mengin-Lecreulx D, Brondello JM, Vincent SP, Sinaÿ P.

Chemistry. 2003 Dec 5;9(23):5888-98.

PMID:
14673861
19.

DNA damage checkpoint control of mitosis in fission yeast.

Rhind N, Baber-Furnari BA, Lopez-Girona A, Boddy MN, Brondello JM, Moser B, Shanahan P, Blasina A, McGowan C, Russell P.

Cold Spring Harb Symp Quant Biol. 2000;65:353-9. Review. No abstract available.

PMID:
12760050
20.

Mechanism of caffeine-induced checkpoint override in fission yeast.

Moser BA, Brondello JM, Baber-Furnari B, Russell P.

Mol Cell Biol. 2000 Jun;20(12):4288-94.

Supplemental Content

Loading ...
Support Center